Documents & Downloads

Evomonoside

Cardiac Glycoside Compound

Evomonoside is a cardiac glycoside compound that exhibits notable in vitro anticancer activity, particularly against gastric cancer cell lines, with nanomolar inhibitory concentrations. While it demonstrates significant potential in cancer research, it is important to consider its associated cardiac toxicity risks, including arrhythmias and conduction abnormalities. Evomonoside serves as a valuable reagent for studying gastric cancer and investigating the mechanisms of cardiac glycosides in therapeutic contexts.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	508-93-0
Applications	Cardiac Glycoside Compound
Formula	C₂₉H₄₄O₈
Molecular Weight	520.65
SMILES	O[C@@]12[C@@]3([H])[C@@](CC[C@@]1([C@@H](C(CO4)=CC4=O)CC2)C)([H])[C@@]5([C@](C[C@H](CC5)O[C@H]6[C@@H]([C@@H]([C@H]([C@@H](O6)C)O)O)O)([H])CC3)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.